97296 ⎘
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonist
#4502Compositions and methods for inhibiting PDGFRβ and VEGF-A
#4503Recombinant production of mixtures of antibodies
#4504Methods for treating colorectal cancer
#4505Methods for treating breast cancer
#4506IAP BIR DOMAIN BINDING COMPOUNDS
#4507BISPECIFIC BINDING MOLECULES FOR ANTI-ANGIOGENESIS THERAPY
#4508Anti-PSGL-1 antibodies
#4509ANTI-PlGF ANTIBODIES AND METHODS USING SAME
#4510Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma
#4511Anti-HER3 antibodies and uses thereof
#4512PD-1 specific antibodies and uses thereof
#4513PD-1 specific antibodies and uses thereof
#4514Methods for treating pancreatic cancer
#4515Humanized monoclonal antibodies and methods of use
#4516Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases
#4517Therapeutic agents for alzheimer's disease and cancer
#4518Methods for Treating Cancers Comprising K-ras Mutations
#4519ANTI-EPCAM ANTIBODIES THAT INDUCE APOPTOSIS OF CANCER CELLS AND METHODS USING SAME
#4520Antibodies against human CSF-1R and uses thereof
#4521ANTI CD37 ANTIBODIES
#4522COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABINE AND/OR MITOXANTRONE
#4523IGF-II/IGF-IIE BINDING PROTEINS
#4524Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19
#4525ANTI-NUCLEIC ACID ANTIBODY INDUCING CELL DEATH OF CANCER CELLS AND COMPOSITION FOR PREVENTING OR TREATING CANCERS COMPRISING THE SAME
#4526Anti-VEGF antibodies
#4527Multi-Specific Binding Proteins Targeting B Cell Disorders
#4528Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#4529EBI3, DLX5, NPTX1 AND CDKN3 FOR TARGET GENES OF LUNG CANCER THERAPY AND DIAGNOSIS
#4530Means for the diagnosis and therapy of CTCL
#4531ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#4532Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders
#4533Binding member which binds to both lewis-Y and lewis-B haptens, and its use for treating cancer
#4534HUMAN ANTIBODIES TO HUMAN DELTA LIKE LIGAND 4
#4535FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS
#4536Antibody specifically binding to angiopoietin-2 and use thereof
#4537HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3) AND USES THEREOF
#4538Anti-AREG/HB-EGF antibodies and treatment
#4539Fully human anti-human NKG2D monoclonal antibodies
#4540PRLR-specific antibody and uses thereof
#4541Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
#4542Antibodies and derivatives thereof
#4543Monoclonal antibodies that recognize neurospheres or neural progenitor cells
#4544ANTI-VEGF-C ANTIBODIES AND METHODS USING SAME
#4545Engineered anti-IL-23P19 antibodies
#4546Multispecific antibodies
#4547NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF
#4548Compositions and methods for diagnosing and treating cancer
#4549Antibodies against cancer target block tumor growth, angiogenesis and metastatis
#4550Compositions and methods for the diagnosis and treatment of tumor
#4551Survivin, a protein that inhibits cellular apoptosis, and its modulation
#4552Anti-CD79B antibodies and immunoconjugates and methods of use
#4553VHZ for diagnosis and treatment of cancers
#4554Method of treating cancer
#4555Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1
#4556Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof
#4557Anti-human IL-21 monoclonal antibodies
#4558Methods of treating cancer by administering antibodies to CD200
#4559HUMANIZED ANTI-ERBB2 ANTIBODIES AND TREATMENT WITH ANTI-ERBB2 ANTIBODIES
#4560Antibodies Directed to CD20 and Uses Thereof
#4561Dendritic cell marker and uses thereof
#4562ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#4563HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use
#4564Antibodies to EphA3
#4565HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#4566Method for making heteromultimeric molecules
#4567Antibodies against ERBB3 and uses thereof
#4568Tumor specific antibodies and uses therefor
#4569AMINO ACID SEQUENCES DIRECTED AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF CONDITIONS AND DISEASES CHARACTERIZED BY EXCESSIVE AND/OR PATHOLOGICAL ANGIOGENESIS OR NEOVASCULARIZATION
#4570HUMAN ANTIBODY CAPABLE OF INDUCING APOPTOSIS
#4571Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
#4572HER2 antibody composition
#4573Humanization of rabbit antibodies using a universal antibody framework
#4574ADAM-15 antibodies and immunogenic peptides
#4575Monoclonal antibodies to progastrin and their uses
#4576Anti-REG4 Antibodies
#4577Therapeutic DLL4 binding proteins
#4578Compositions against cancer antigen LIV-1 and uses thereof
#4579Monoclonal antibodies against gonadotropin-releasing hormone receptor
#4580Heparin-binding epidermal growth factor-like growth factor binding proteins
#4581ANTI-ALK1 ANTIBODIES AND USES THEREOF
#4582Treatment of uveitis
#4583COMBINATION TREATMENT FOR OCULAR DISEASES
#4584Multivalent Antibodies and Uses Therefor
#4585Multivalent immunoglobulin-based bioactive assemblies
#4586METHODS, COMPOSITIONS AND APPARATUSES FOR FACILITATING REGENERATION
#4587CD40 ANTIBODY FORMULATION AND METHODS
#4588Antibody specifically binding to c-Met
#4589Anti-CD19 antibodies and uses in B cell disorders
#4590Treating basal-like genotype cancers
#4591Blockage of interferon-gamma for prevention of polymicrobial synergy
#4592Treatment of chronic prostatitis
#4593Fully human anti-VEGF antibodies and methods of using
#4594Use of Substances for Sensitization of Tumor Cells to Radiation and/or Chemotherapy
#4595Antibody Capable of Binding Specifically to AB-Oligomer, and Use Thereof
#4596Anti-c-Met antibody
#4597Non-functional P2Xreceptor
#4598ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#4599ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#4600INHIBITION OF POST-RADIATION TUMOR GROWTH
#4601Methods of using antibodies against human IL-22
#4602Anti-human interleukin-20 antibodies
#4603Treatment method for epithelial cancerous organism
#4604ANTI-FLT3 ANTIBODIES
#4605Dual variable domain immunoglobulins and uses thereof
#4606Treatment of neurological conditions
#4607LYMPHOCYTE CONTROL OF OBESITY AND INSULIN RESISTANCE
#4608SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER
#4609Treatment of MS with goat serum
#4610Method for administering homeopathically potentiated antibodies against mediator of inflammation
#4611Method of inhibiting osteoclast activity
#4612Anti-FGF19 antibodies and methods using same
#4613NOVEL ANTIBODIES AGAINST CANCER TARGET BLOCK TUMOR GROWTH, ANGIOGENESIS AND METASTASIS
#4614Anti-CXCR4 antibodies
#4615POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSMETHODS FOR
#4616ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#4617ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#4618Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
#4619Anti-cancer drug
#4620Methods of treating conditions using anti-IL-6 antibodies
#4621Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal antibody variable regions
#4622ANTI-VEGF ANTIBODIES
#4623Immunopotentiative composition
#4624NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF
#4625Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling
#4626FULLY HUMAN ANTI-VEGF ANTIBODIES AND METHODS OF USING
#4627THERAPEUTIC METHODS AND COMPOSITIONS
#4628Therapeutic Binding Molecules
#4629Humanized antibody compositions and methods for binding lysophosphatidic acid
#4630Endoglin antibodies
#4631SPECIFIC BINDING PROTEINS AND USES THEREOF
#4632Compositions and methods relating to anti-IGF-1 receptor antibodies
#4633Antibodies against CDCP1 for the treatment of cancer
#4634COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC
#4635Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
#4636Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
#4637Targeted immunoconjugates
#4638ErbB antagonists for pain therapy
#4639CA6 antigen-specific cytotoxic conjugate and methods of using the same
#4640Neutralizing human anti-IGFR antibody
#4641Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
#4642ANTIBODY HAVING AN IMMUNE-ENHANCEMENT FUNCTION
#4643TIE COMPLEX BINDING PROTEINS
#4644Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
#4645ANTITUMOR EFFECTS OF INSULIN-RESPONSIVE DNA BINDING PROTEIN-1 (IRDBP-1)
#4646IL-23 antagonists
#4647METHODS AND COMPOSITIONS FOR THE TREATMENT OF RECEPTOR TYROSINE KINASE MEDIATED DISEASES OR DISORDERS
#4648Polypeptides involved in immune response
#4649Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
#4650METHOD OF ENHANCEMENT OF CYTOTOXICITY IN ANTIBODY MEDIATED IMMUNE RESPONSES
#4651Humanized anti-CDCP1 antibodies
#4652VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS
#4653ANTI-VEGF ANTIBODIES
#4654METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
#4655Cytotoxic immunoglobulin
#4656LUCA2 and Antibodies That Bind Thereto
#4657COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#4658Anti-GM-CSF antibodies
#4659Stabilized angiopoietin-2 antibodies and uses thereof
#4660Monoclonal antibody capable of binding to anexelekto, and use thereof
#4661Dual Variable Domain Immunoglobulins and Uses Thereof
#4662TREATMENT OF PRION PROTEIN RELATED DISEASES
#4663Methods and Compositions for Localized Secretion of Anti-CTLA-4 Antibodies
#4664Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof
#4665Human anti-IL-23 antibodies, compositions, methods and uses
#4666PARASPORIN-1 RECEPTOR AND USE THEREOF
#4667Antibodies to interleukin-6
#4668Anti-VEGFR monoclonal antibody, method of making and uses thereof
#4669Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
#4670Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
#4671ANTI-ErbB2 ANTIBODIES
#4672Methods For Treating Diseases Using Antibodies to Aminophospolipids
#4673Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
#4674Carbohydrate-containing pan cancer marker
#4675ANTIBODIES FOR TREATING CANCER
#4676High affinity human antibodies to human angiopoietin-2
#4677Methods For Inducing Autolysis In Infectious Bacteria
#4678INHIBITION OF TUMOR METASTASIS
#4679Engineered anti-TSLPR antibodies
#4680Targeted binding agents directed to PDGRF-alpha and uses thereof
#4681Antibodies and related molecules that bind to 161P2F10B proteins
#4682Anti-VEGF antibodies
#4683Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof
#4684Anti CXCR4 antibodies and their use for the treatment of cancer
#4685Ex vivo methods for targeting or depleting acute myeloid leukemia cancer stem cells
#4686Soluble IL-17RA/RC fusion proteins and related methods
#4687Screening method for predicting susceptibility to breast cancer
#4688Methods for diagnosing and treating neuroendocrine cancer
#4689Anti-IL 13 antibodies and uses thereof
#4690Anti-VEGF antibodies
#4691Methods of treating acute myeloid leukemia by blocking CD47
#4692ANTI-IGF1R
#4693APO-2 receptor polypeptides
#4694Dual Variable Domain Immunoglobulins and Uses Thereof
#4695NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 58P1D12 USEFUL IN TREATMENT AND DETECTION OF CANCER
#4696METHODS OF MODULATING THE OX40 RECEPTOR TO TREAT CANCER
#4697Antibodies to TGFβ
#4698Anti-FLT3 antibodies
#4699Antibodies to Apo-2 receptor polypeptides
#4700Methods of treating pancreatic or liver cancer using hedgehog antagonists
#4701Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
#4702Anti-C35 antibody combination therapies and methods
#4703ANTIBODIES TO ZALPHA11 CYTOKINE RECEPTORS
#4704Engineered Anti-IL-23 Antibodies
#4705Anti-IL-6/IL-6R antibodies and methods of use thereof
#4706USES OF ANTI-CD40 ANTIBODIES
#4707DR4 ANTIBODIES AND USES THEREOF
#4708Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#4709TWEAK RECEPTOR AGONISTS AS ANTI-ANGIOGENIC AGENTS
#4710Cell growth inhibitors containing anti-glypican 3 antibody
#4711Combinations of antibodies selective for DR5 and other therapeutic agents
#4712METHODS OF TREATING CANCER USING IL-21
#4713Method of treating cancer with DLL4 antagonist and chemotherapeutic agent
#4714METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES
#4715AXL antibodies
#4716ANTAGONIST ANTIBODIES OF PROTEASE ACTIVATED RECEPTOR-1 (PAR1)
#4717ANTI-CD20 THERAPEUTIC COMPOSITIONS AND METHODS
#4718Alpha 5-beta 1 antibodies and their uses
#4719Method for determining immune system affecting compounds
#4720Multispecific antibodies
#4721LM-1 ANTIBODIES, FUNCTIONAL FRAGMENTS, LM-1 TARGET ANTIGEN, AND METHODS FOR MAKING AND USING SAME
#4722Bispecific, tetravalent antigen binding proteins
#4723Human monoclonal antibodies against CD30
#4724METHODS OF TREATING CANCER USING IL-21
#4725KID3 and KID3 antibodies that bind thereto
#4726IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES
#4727NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF
#4728VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#4729COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#4730Bispecific antigen binding proteins
#4731Compositions and methods for diagnosing and treating cancer
#4732Inhibition of angiogenesis
#4733METHODS OF TREATING CANCER USING IL-21
#4734METHODS OF TREATING CANCER USING IL-21
#4735METHODS OF TREATING CANCER USING IL-21
#4736METHODS OF TREATING CANCER USING IL-21
#4737Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
#4738Compositions and methods for the diagnosis and treatment of tumor
#4739Liposomes comprising duramycin and anti-viral agents
#4740Uses of monoclonal antibody 8H9
#4741Antibodies against human CCN1 and uses thereof
#4742Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#4743Antibodies immunoreactive with heregulin-coupled HER3
#4744Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors
#4745METHODS OF TREATING CANCER USING IL-21
#4746Use of soluble CEACAM8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis
#4747Human monoclonal antibodies to epidermal growth factor receptor
#4748Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
#4749COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#4750Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
#4751Anti-estrogen and immune modulator combinations for treating breast cancer
#4752IMMUNOGLOBULINS
#4753ANTIBODIES TO TREAT CANCER
#4754Neutralizing monoclonal antibody against human DLL4
#4755EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
#4756DISEASE TREATMENT VIA ANTIMICROBIAL PEPTIDE INHIBITORS
#4757Humanised antibodies with anti-tumour activity
#4758Binding domain of reticulocyte binding proteins
#4759COMBINATION THERAPY TO INHIBIT T CELL EFFECTOR FUNCTION
#4760Cytokine zalpha11 ligand antibodies
#4761CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#4762HUMANIZED ANTIBODY
#4763ANTI-DLL4 ANTIBODIES AND METHODS USING SAME
#4764Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
#4765REDUCER OF IMMUNOSUPPRESSION BY TUMOR CELL AND ANTITUMOR AGENT USING THE SAME
#4766Humanized anti-CD4 antibody with immunosuppressive properties
#4767Crystal structures and methods using same
#4768Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation
#4769High affinity human antibodies to human IL-4 receptor
#4770Therapeutic Agent
#4771Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies
#4772Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions
#4773SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOEITIN-2
#4774Anti-CD100 neutralizing neutralizing antibodies and methods of using the same
#4775Antibodies to OX-2/CD200 and uses thereof
#4776Humanized anti-EGFL7 antibodies and methods using same
#4777Anti-CXCR4 antibodies
#4778USE OF VEGFR-2 INHIBITORS FOR TREATING METASTATIC CANCER
#4779Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer
#4780Antibodies against nerve growth factor (NGF) with enhanced in vivo stability
#4781EPHA2 MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
#4782N-CADHERIN: TARGET FOR CANCER DIAGNOSIS AND THERAPY
#4783Antibody specific for the Tn antigen for the treatment of cancer
#4784Humanized monoclonal antibodies to hepatocyte growth factor
#4785Breast cancer eradication program
#4786Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer
#4787Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient
#4788PEPTIDES OF IL-2
#4789Method to treat using antagonistic anti-hTNFSF13b human antibodies
#4790Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (VEGF)
#4791EMP2 antibodies and their therapeutic uses
#4792Engineered anti-IL-23P19 antibodies
#4793Antigenic GM-CSF peptides and antibodies to GM-CSF
#4794Anti-CD74 immunoconjugates and methods of use
#4795Polypeptides, antibody variable domains and antagonists
#4796Antibodies against the ectodomain of ErbB3 and uses thereof
#4797Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents
#4798Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
#4799Anti-Cancer Activity of an Anti-Thymidine Kinase Monoclonal Antibody
#4800Treatment of cancer with novel anti-IL13 monoclonal antibodies